EV/EBITDA
9.91
-0.28-2.75%
Sat, 04 Jan 2025 00:55:19 GMT
Summary:
Catalyst Pharmaceuticals EV/EBITDA is currently 9.91, with a fall of -0.28 (-2.75%) during the most recent trading day. Over the past year, it has dropped by -3.85 (-27.98%). CPRX EV/EBITDA is now -83.23% below its all-time high of 59.10.CPRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -2.8% |
| 1 m1 month | -3.3% |
| 3 m3 months | +8.9% |
| 6 m6 months | -20.3% |
| ytdytd | +2.3% |
| 1 y1 year | -28.0% |
| 5 y5 years | +6.8% |
CPRX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 10.32 | -4.0% | 9.69 | +2.3% |
| 3 m | 3 months | 11.63 | -14.8% | 8.98 | +10.4% |
| 6 m | 6 months | 17.69 | -44.0% | 8.84 | +12.1% |
| 1 y | 1 year | 17.69 | -44.0% | 8.84 | +12.1% |
| 3 y | 3 years | 21.17 | -53.2% | 6.86 | +44.5% |
| 5 y | 5 years | 21.17 | -53.2% | 4.68 | +111.8% |
| alltime | all time | 59.10 | -83.2% | -57.59 | +117.2% |
Catalyst Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 9.91(+2.3%) |
| 2024 | 9.69(-29.7%) |
| 2023 | 13.78(-16.2%) |
| 2022 | 16.44(+63.1%) |
| 2021 | 10.08(+93.1%) |
| 2020 | 5.22(-44.1%) |
| 2019 | 9.34(-282.1%) |
| 2018 | -5.13(-72.2%) |
| 2017 | -18.43(+383.7%) |
| 2016 | -3.81(-55.6%) |
| Date | Value |
|---|---|
| 2015 | -8.58(-36.3%) |
| 2014 | -13.47(+34.2%) |
| 2013 | -10.04(+210.8%) |
| 2012 | -3.23(-24.5%) |
| 2011 | -4.28(+24.8%) |
| 2010 | -3.43(+600.0%) |
| 2009 | -0.49(-60.8%) |
| 2008 | -1.25(-77.0%) |
| 2007 | -5.44(-64.9%) |
| 2006 | -15.50 |
FAQ
- What is Catalyst Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Catalyst Pharmaceuticals?
- What is CPRX EV/EBITDA year-to-date change?
- What is Catalyst Pharmaceuticals EV/EBITDA year-on-year change?
What is Catalyst Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of CPRX is 9.91
What is the all time high EV/EBITDA for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high EV/EBITDA is 59.10
What is CPRX EV/EBITDA year-to-date change?
Catalyst Pharmaceuticals EV/EBITDA has changed by +0.22 (+2.27%) since the beginning of the year
What is Catalyst Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, CPRX EV/EBITDA has changed by -3.85 (-27.98%)